Aromadendrene
Based on 1 Customer Validation
Aromadendrene ((+)-Aromadendrene) is a potent antibacterial agent. Aromadendrene can be isolated from Eucalyptus globulus. Aromadendrene disrupts cellular biofilms via high lipophilicity and interferes with protein conformation through protein alkylation. Aromadendrene is applicable to research related to multidrug-resistant bacterial infections.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 96.00%
- CAS No.: 489-39-4
- 화학식: C15H24
- 분자량:204.35
-
보관:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- Protocol
- 순도&문서
- References
-
Help & FAQs
-
HY-N8411R
Aromadendrene (Standard)Reference Standard -
HY-N0303
IdebenoneMitochondrial Protectant/Antioxidant -
HY-N9515
Diallyl tetrasulfideDiallyl Tetrasulfide -
HY-N3463
Isopimaric acidConifer Defense Compound -
HY-34386
6(5H)-PhenanthridinonePARP-1 Inhibitor -
HY-130187S
Sapienic acid-d19Stable Isotope -
HY-152055S
Glufosinate-d3 hydrochlorideStable Isotope -
HY-N10268
3-HydroxyterphenyllinAnti-cancer Agent -
HY-N0303R
Idebenone (Standard)Mitochondrial Protectant/Antioxidant -
HY-N10263
Palmarumycin C3Anti-infection Agent -
HY-W779504
b-CortoloneCortisol Metabolite -
HY-125322
Reveromycin CPolyketide
Biological Activity
제품 설명
In Vitro
Aromadendrene ((+)-Aromadendrene) (0.12-8 mg/mL; 24 h) inhibits and kills the growth of Gram-positive bacteria (including MRSA and VRE), shows limited activity against Acinetobacter baumanii, and also inhibits the growth of yeast, with a minimum MIC of 0.12 mg/mL against Streptococcus pyogenes[1].
Aromadendrene (0.03-0.25 mg/mL; 24 h) exerts synergistic anti-MRSA, anti-Bacillus subtilis, anti-Staphylococcus aureus, and anti-Streptococcus pyogenes activities when used in combination with 1,8-Cineole (HY-N0066)[1].
Aromadendrene (0.03-0.06 mg/mL; 2-24 h) exhibits bactericidal activity in cultures of Streptococcus pyogenes and MRSA, and shows a significant synergistic bactericidal kinetic effect when used in combination with 1,8-Cineole.
Aromadendrene acts on vascular K+ and Ca2+ channels through hydrophobic interactions with key amino acid residues[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MRSA, B. subtilis, S. aureus, and S. pyogenes
-
Concentration:0.03, 0.06, 0.12, 0.25, 0.5, 1 mg/mL
-
Incubation Time:24 h
-
Result:Reduced the MIC values for most tested strains when used in combination with 1,8-cineole, mainly demonstrating an additive effect, and showing a synergistic antibacterial effect at specific concentration combination.
-
Cell Line:S. pyogenes and MRSA
-
Concentration:0.03, 0.06 mg/mL (for S. pyogenes); 0.25 mg/mL (for MRSA)
-
Incubation Time:2, 4, 6, 8, 24 h
-
Result:Significantly reduced the number of viable bacterial colonies within 24 hours; when combined with a high dose of 1,8-cineole, the number of viable cells decreased by at least 2-5 log10, exhibiting a significant synergistic bactericidal effect.
Chemical Information
-
CAS No. 489-39-4
-
Appearance Liquid (Density: 0.9166 g/cm3)
-
분자량 204.35
-
화학식 C15H24
-
Color Colorless to light yellow
-
SMILES
C=C1CC[C@]2([H])[C@](C2(C)C)([H])[C@]3([H])[C@H](C)CC[C@@]13[H]
-
Synonyms
(+)-Aromadendrene
-
Structure Classification
-
Initial Source
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
용액&용해도
In Vitro:
DMSO : ≥ 100 mg/mL (489.36 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (12.23 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
순도&문서
-
Data Sheet (299 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Mulyaningsih S, et al. Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2010 Nov;17(13):1061-6. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.8936 mL | 24.4678 mL | 48.9356 mL | 122.3391 mL |
| 5 mM | 0.9787 mL | 4.8936 mL | 9.7871 mL | 24.4678 mL | |
| 10 mM | 0.4894 mL | 2.4468 mL | 4.8936 mL | 12.2339 mL | |
| 15 mM | 0.3262 mL | 1.6312 mL | 3.2624 mL | 8.1559 mL | |
| 20 mM | 0.2447 mL | 1.2234 mL | 2.4468 mL | 6.1170 mL | |
| 25 mM | 0.1957 mL | 0.9787 mL | 1.9574 mL | 4.8936 mL | |
| 30 mM | 0.1631 mL | 0.8156 mL | 1.6312 mL | 4.0780 mL | |
| 40 mM | 0.1223 mL | 0.6117 mL | 1.2234 mL | 3.0585 mL | |
| 50 mM | 0.0979 mL | 0.4894 mL | 0.9787 mL | 2.4468 mL | |
| 60 mM | 0.0816 mL | 0.4078 mL | 0.8156 mL | 2.0390 mL | |
| 80 mM | 0.0612 mL | 0.3058 mL | 0.6117 mL | 1.5292 mL | |
| 100 mM | 0.0489 mL | 0.2447 mL | 0.4894 mL | 1.2234 mL |
Aromadendrene Related Classifications
HY-N8411 Related Classifications
Powered by Bioz